Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulator
US11414439B2 · kind B2 · utility
6Cited by
18References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2019 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | May 12, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/47
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This disclosure provides modulators of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), pharmaceutical compositions containing at least one such modulator, methods of treatment of cystic fibrosis by administering such modulators and pharmaceutical compositions, and processes for making such modulators.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.